Bergen, Norway, 13 November 2024: Today, Lifecare ASA (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes its Q3 2024 financial report and operational update. Lifecare continued to build positive momentum towards market introduction of Sencell, our innovative next- generation Continuous Glucose Monitor (CGM). Apart from […]
Read more